Skip to content

Robert B. Belshe, MD

NPI 1881700219ActiveIndividual· Internal Medicine, Infectious Disease· Saint Louis, MO

Internal Medicine, Infectious Disease (MD) in Saint Louis, Missouri, licensed in MO, with an NPI issued in August 2006. Part D covered 20 prescriptions written in 2024, 70% of them generic. Pfizer Inc. was the largest of 3 companies reporting payments in 2025, $25,538 in all, mostly consulting fees.

Overview

NPI1881700219
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedAug 21, 2006
Last updated in NPPESSep 25, 2008

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Infectious Disease Primary207RI0200XR4J89MO

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)20 · 22 30-day fills
Total drug cost$326.64
Generic share70% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$25,538 · 15 payments from 3 companies
  • 2024$36,185 · 17 payments from 4 companies

Top paying companies in 2025

CompanyAmountPayments
Pfizer Inc.$13,03812
Sanofi Pasteur Inc.$11,3901
Merck Sharp & Dohme LLC$1,1102

What the 2025 payments were for

  • Consulting Fee$25,538 · 15 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Infectious Disease providers in Saint Louis

All Internal Medicine, Infectious Disease providers in Missouri →